NCT00084058 - Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

December 31, 2006

Conditions

HIV Infections

Interventions

DRUG

Lopinavir/ritonavir

DRUG

Saquinavir

Trial Locations (15)

10037

Harlem Hosp. Ctr. NY NICHD CRS, New York

10461

Jacobi Med. Ctr., The Bronx

27705

DUMC Ped. CRS, Durham

35233

UAB, Dept. of Ped., Div. of Infectious Diseases, Birmingham

60614

Chicago Children's CRS, Chicago

90801

Long Beach Memorial Med. Ctr., Miller Children's Hosp., Long Beach

94143-0105

UCSF Pediatric AIDS CRS, San Francisco

70112-2699

Tulane/LSU Maternal/Child CRS, New Orleans

Unknown

Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases, Baltimore

HMS - Children's Hosp. Boston, Div. of Infectious Diseases, Boston

Nyu Ny Nichd Crs, New York

San Juan City Hosp. PR NICHD CRS, San Juan

14642-0001

Strong Memorial Hospital Rochester NY NICHD CRS, Rochester

38105-2794

St. Jude/UTHSC CRS, Memphis

00936-5067

Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS, San Juan

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH